Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Edmund Cannon currently holds 61,873 shares of CANCER GENETICS, INC (CGIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edmund Cannon has been a net buyer of CGIX stock. They have purchased $10.0K and sold $0 worth of shares.
Edmund Cannon's most recent insider trade was on Jan 31, 2019, when they purchased 43,479 shares at $0.23 per share.
Edmund Cannon serves as Executive at CANCER GENETICS, INC (CGIX). They have executed 5 insider transactions totaling $10.0K over their tenure at the company.
Edmund Cannon holds the position of Executive at CANCER GENETICS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Edmund Cannon has shown a buying trading pattern, with $10.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Edmund Cannon was on Jan 31, 2019, when they purchased $10.0K worth of CGIX shares. This transaction involved 43,479 shares at $0.23 per share.
Edmund Cannon currently owns 61,873 shares of CANCER GENETICS, INC (CGIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Edmund Cannon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Edmund Cannon has 5 Form 4 filings on record as an insider at CANCER GENETICS, INC.
Set alerts for Edmund Cannon and 40,000+ other insiders.